TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY Growth hormone, Hologic, Hypopituitarism, Longitudinal, Slovakia, Treatment (anti-osteoporotic treatments), Vitamin D
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide Alendronate, Bisphosphonate, Glucocorticoids, Longitudinal, Osteoporosis, Prednisone, Secondary osteoporosis, Teriparatide, Treatment (anti-osteoporotic treatments), USA
The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal Hologic, Hormone replacement therapy, Longitudinal, Osteoporosis, Switzerland, Treatment (anti-osteoporotic treatments)
Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant Canada, Glucocorticoids, Longitudinal, Secondary osteoporosis, Stem cell transplant, Treatment (anti-osteoporotic treatments)
Trabecular bone score in patients with liver transplants after 1 year of risedronate treatment. Bisphosphonate, Calcium, Hologic, Liver, Longitudinal, Risedronate, Secondary osteoporosis, Spain, Transplant, Treatment (anti-osteoporotic treatments), Vitamin D
The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study Austria, Diet, GE-Lunar, Longitudinal, Obesity, Physical activity, Treatment (anti-osteoporotic treatments)
Seven years of follow up of trabecular bone score, bone mineral density, body composition and quality of life in adults with growth hormone deficiency treated with rhGH replacement in a single center Growth hormone, Hologic, Longitudinal, Secondary osteoporosis, Spain, Treatment (anti-osteoporotic treatments)
Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trial Aromatase inhibitor, Bisphosphonate, Breast cancer, Cancer, Hologic, Longitudinal, Risedronate, Secondary osteoporosis, Treatment (anti-osteoporotic treatments), USA
Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy. Aromatase inhibitor, Bisphosphonate, Breast cancer, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Treatment (anti-osteoporotic treatments), Zoledronate
Effect of denosumab on bone mineral density and trabecular bone score in postmenopausal osteoporosis: Three-year treatment results Bulgaria, Denosumab, GE-Lunar, Longitudinal, Osteogenesis imperfecta, Osteoporosis, Treatment (anti-osteoporotic treatments)